ACM
Ayrshire Capital Management Portfolio holdings
AUM
$208M
This Quarter Return
+10.74%
1 Year Return
+18.61%
3 Year Return
+76.93%
5 Year Return
+120.41%
10 Year Return
–
AUM
$143M
AUM Growth
+$143M
(+6.2%)
Cap. Flow
-$3.13M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
50
New
2
Increased
30
Reduced
9
Closed
3
Top Buys
| 1 |
Arthur J. Gallagher & Co
AJG
|
$2.97M |
| 2 |
KLA
KLAC
|
$2.79M |
| 3 |
Littelfuse
LFUS
|
$1.04M |
| 4 |
Amazon
AMZN
|
$126K |
| 5 |
Zoetis
ZTS
|
$116K |
Top Sells
| 1 |
Verisk Analytics
VRSK
|
$3.26M |
| 2 |
Stryker
SYK
|
$2.98M |
| 3 |
UnitedHealth
UNH
|
$2.16M |
| 4 |
Home Depot
HD
|
$853K |
| 5 |
Johnson & Johnson
JNJ
|
$533K |
Sector Composition
| 1 | Technology | 28.18% |
| 2 | Healthcare | 19.43% |
| 3 | Financials | 16.29% |
| 4 | Consumer Staples | 12.36% |
| 5 | Consumer Discretionary | 12.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Arthur J. Gallagher & Co
AJG
$77.5B
| $2.97M | 2.08% |
+15,759
| New | +$2.97M |
|
27
Nike
NKE
$112B
| $2.94M | 2.06% |
25,159
+283
| +1% | +$33.1K |
|
28
Bank of America
BAC
$370B
| $2.82M | 1.97% |
85,108
+13
| +0% | +$431 |
|
|
29
KLA
KLAC
$112B
| $2.79M | 1.95% |
+7,395
| New | +$2.79M |
|
30
SPDR S&P 500 ETF Trust
SPY
$650B
| $1.19M | 0.83% |
3,103
| – | – |
|
31
JPMorgan Chase
JPM
$814B
| $1.17M | 0.82% |
8,716
+344
| +4% | +$46.1K |
|
32
Ares Capital
ARCC
$15.7B
| $1.03M | 0.72% |
55,978
+2,809
| +5% | +$51.9K |
|
33
ConocoPhillips
COP
$123B
| $953K | 0.67% |
8,080
+267
| +3% | +$31.5K |
|
34
Qualcomm
QCOM
$168B
| $941K | 0.66% |
8,561
+252
| +3% | +$27.7K |
|
35
American Tower
AMT
$95.6B
| $933K | 0.65% |
4,405
+241
| +6% | +$51.1K |
|
36
Amgen
AMGN
$155B
| $881K | 0.62% |
3,354
+67
| +2% | +$17.6K |
|
37
SS&C Technologies
SSNC
$21.3B
| $724K | 0.51% |
13,903
+823
| +6% | +$42.8K |
|
38
W.P. Carey
WPC
$14.6B
| $650K | 0.46% |
8,319
+326
| +4% | +$25.5K |
|
39
Salesforce
CRM
$241B
| $622K | 0.44% |
4,688
-445
| -9% | -$59K |
|
40
Gilead Sciences
GILD
$140B
| $464K | 0.32% |
5,400
| – | – |
|
41
iShares Core Dividend Growth ETF
DGRO
$33.4B
| $365K | 0.26% |
7,297
+562
| +8% | +$28.1K |
|
42
SPDR S&P MidCap 400 ETF Trust
MDY
$23.4B
| $358K | 0.25% |
809
| – | – |
|
43
S&P Global
SPGI
$166B
| $335K | 0.23% |
1,000
| – | – |
|
44
Golub Capital BDC
GBDC
$3.93B
| $268K | 0.19% |
20,348
-952
| -4% | -$12.5K |
|
45
Berkshire Hathaway Class B
BRK.B
$1.08T
| $263K | 0.18% |
852
| – | – |
|
46
Enbridge
ENB
$105B
| $227K | 0.16% |
5,795
+74
| +1% | +$2.89K |
|
47
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.36B
| – | – |
-7,100
| Closed | -$337K |
|
|
48
Stryker
SYK
$149B
| – | – |
-14,692
| Closed | -$2.98M |
|
|
49
Verisk Analytics
VRSK
$37.3B
| – | – |
-19,128
| Closed | -$3.26M |
|